• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 9, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

PCORI offers up to $308.5 million through new funding opportunities

Bioengineer by Bioengineer
January 10, 2023
in Health
Reading Time: 3 mins read
0
Logo
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

January 10, 2023

Logo

Credit: PCORI®; https://www.pcori.org/about/governance/trademark-usage-guidelines

January 10, 2023

 

WASHINGTON, DC – The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for nine funding opportunities that offer up to $308.5 million in total funding. The latest PCORI Funding Announcements (PFAs) include up to $285 million for comparative clinical effectiveness research (CER) studies that compare health care options to help patients and other stakeholders make better-informed health care choices.

 

“With these first funding opportunities of 2023, PCORI proudly continues its vital work as a leading funder of patient-centered comparative clinical effectiveness research,” said PCORI Executive Director Nakela L. Cook, M.D., M.P.H. “For patients, caregivers and clinicians faced with myriad health care options, sound data about which care approaches work best for different people in different circumstances is essential.”

 

The largest funding announcement, the Broad Pragmatic Studies PFA, seeks proposals for CER studies aligned with PCORI’s National Priorities for Health. Proposals also may align with topic themes that speak to health issues facing large numbers of Americans and which arose from stakeholder input during PCORI’s recent strategic planning efforts. PCORI offers up to $162 million to fund studies through this PFA.

 

The innovative Partnering Research and Community Organizations for Novel Health Equity Research: Addressing Health Systems Factors and Social Determinants of Maternal Health Targeted PFA (Partner Targeted PFA) offers up to $63 million for studies comparing interventions that address both clinical conditions and social determinants of health to improve maternal health outcomes, a key research focus for PCORI. Studies are required to have shared leadership between researchers and community-based organizations that bring deep knowledge of members’ lived experiences and the factors affecting their health and ability to access and use available care options.

 

Two other Targeted PFAs seek proposals for CER studies focused on brief interventions for adolescent alcohol use and prevention and early identification and treatment of delirium in older adults. PCORI offers up to $60 million through these two PFAs.

 

Three implementation funding announcements seek proposals for projects to implement results of PCORI-funded research and advance approaches to effective shared decision making in practice settings. These PFAs aim to accelerate the movement of evidence developed with PCORI research funding toward practical use in improving health care and health outcomes. PCORI offers up to $23.5 million to support projects through these three PFAs.

 

An additional PFA seeks proposals for studies focused on strengthening and enhancing the science of engagement in health research. This groundbreaking initiative is a natural evolution of PCORI’s leadership in funding patient-centered research and supports more strategic approaches to promoting robust engagement, inclusion and diversity in health research. PCORI offers up to $4.5 million through this PFA.

 

Another PFA seeks proposals for studies on improving methods to conduct patient-centered CER to enhance scientific rigor across this field of research. PCORI offers up to $12 million through this PFA.

 

“Guided by our National Priorities for Health, PCORI’s latest funding opportunities build on the organization’s success funding research addressing health care challenges that confront families every day and are designed to generate research that provides patients and other health care decision makers with the information they need to make better-informed choices among their health care options,” said Harv Feldman, M.D., MSCE, PCORI’s Deputy Executive Director for Patient-Centered Research Programs. “These diverse opportunities are made possible by the ambitious three-year commitment plan approved by our Board of Governors in December of last year.”

 

To date, PCORI has invested $3.9 billion in patient-centered CER and related projects. Details on the most recent funding announcements are on PCORI’s website.

 

About PCORI

The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed health care decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.

 

Media Contacts

Sofia Kosmetatos

[email protected]

202-738-3335

 



Share12Tweet8Share2ShareShareShare2

Related Posts

Stopping GLP-1RA Linked to Increased Depression and Anxiety in Type 2 Diabetes

July 9, 2026

LINC01929 Drives Breast Cancer via TFRC-Linked Ferroptosis Pathway

July 9, 2026

Epitope Editing Enables Safe Transplantation and In Vivo Cell Selection

July 9, 2026

Study shows lung tumors hijack nervous system to starve body

July 9, 2026

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Plasma Metasurfaces Enable Ultra-Intensive Electromagnetic Field Control

Stopping GLP-1RA Linked to Increased Depression and Anxiety in Type 2 Diabetes

LINC01929 Drives Breast Cancer via TFRC-Linked Ferroptosis Pathway

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 84 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.